Many regions screen infants for congenital adrenal hyperplasia (CAH) due to 21‑hydroxylase deficiency and congenital hypothyroidism —a serious but treatable disease if detected early.
Nurturing Young Lives: Expert Care for Paediatrics and Paediatric Endocrinology
MBBS, MRCPCH, MSc (Paed Sc. - Endrocrinology) (UK)
Dr. Anjana Hulse is a seasoned paediatrician in Bangalore with over 15 years of expertise in paediatric endocrine conditions. Her impressive credentials include an MBBS from Rajiv Gandhi University, an MRCPCH from London, and an MSc in Paediatric Endocrinology from the University of Glasgow. Specializing in diabetes, growth disorders, and childhood obesity, Dr. Hulse is dedicated to providing holistic and personalized care. With a track record of treating over 25,000+ young patients, she is passionate about enhancing children's health by tackling hormonal issues and encouraging healthy growth.
Article on Precocious puberty
https://www.happiesthealth.com/articles/parenting/preventing-early-puberty-gnrh-analogues

This solid academic and clinical foundation in paediatric endocrinology forms the backbone of Dr. Hulse’s expertise in treating complex childhood hormonal and growth-related conditions.
Hulse Clinic 635, 8th Main Rd, Jeewan Griha Colony, phase 2, J. P. Nagar, Bengaluru, Karnataka 560078
Phone: 9480260001
Email: [email protected]
Understanding Childhood Obesity and When to Seek Help
Hormone Testing in Children: What to Expect and Why It Matters
Is Your Child Growing Normally What Parents Should Know About Growth Disorders
Many regions screen infants for congenital adrenal hyperplasia (CAH) due to 21‑hydroxylase deficiency and congenital hypothyroidism —a serious but treatable disease if detected early.
Yes! AI models are being developed to predict a child’s future height and to improve personalized insulin dosing—though data privacy and validation remain challenges.
Bone age helps assess growth by comparing skeletal maturity to chronological age. Significant misalignment can indicate hormone disorders and guide treatment timing.
Puberty blockers (GnRH agonists) can delay early puberty in children with precocious puberty.
If they show rapid height changes, weight issues without clear cause, early puberty signs, body odor in young children, or constant thirst/urination—these warrant specialist evaluation.
Precocious puberty: under 8 (girls) or under 9 (boys) with signs like breast development or testicular enlargement. Delayed: no signs by age 13 in girls or 14 in boys.
Consider timing, underlying causes, genetic growth potential, side‑effects (rare headaches or hip issues), and long‑term monitoring of growth and bone health.
GH therapy is considered for children with hormone deficiencies or idiopathic short stature. Start early—before puberty—for best outcomes. It requires stimulation tests and thorough consultation.
Common tests include hemoglobin A1C, C‑peptide, ketones, and diabetes-related antibodies—particularly if there’s a family history.
There’s no fixed screening age, but experts suggest testing kids around ages 2, and again between 5–7, especially if symptoms like extreme thirst, frequent urination, weight loss, hunger, fatigue, or irritability appear.